Skip to main content
Top
Published in: Current Oncology Reports 6/2022

01-06-2022 | Care | Geriatric Oncology (L Balducci, Section Editor)

Challenges of Survivorship for Older Adults Diagnosed with Cancer

Authors: Margaret I. Fitch, Irene Nicoll, Lorelei Newton, Fay J. Strohschein

Published in: Current Oncology Reports | Issue 6/2022

Login to get access

Abstract

Purpose of Review

The purpose of this brief review is to highlight significant recent developments in survivorship research and care of older adults following cancer treatment. The aim is to provide insight into care and support needs of older adults during cancer survivorship as well as directions for future research.

Recent Findings

The numbers of older adult cancer survivors are increasing globally. Increased attention to the interaction between age-related and cancer-related concerns before, during, and after cancer treatment is needed to optimize outcomes and quality of life among older adult survivors. Issues of concern to older survivors, and ones associated with quality of life, include physical and cognitive functioning and emotional well-being. Maintaining activities of daily living, given limitations imposed by cancer treatment and other comorbidities, is of primary importance to older survivors. Evidence concerning the influence of income and rurality, experiences in care coordination and accessing services, and effectiveness of interventions remains scant for older adults during survivorship.

Summary

There is a clear need for further research relating to tailored intervention and health care provider knowledge and education. Emerging issues, such as the use of medical assistance in dying, must be considered in this population.
Literature
1.
go back to reference Miller KD, Nogueira L, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019;69:363–85.CrossRef Miller KD, Nogueira L, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019;69:363–85.CrossRef
2.
go back to reference Pilleron S, Sarfati D, Janssen-Heijnen M, et al. Global cancer incidence in older adults, 2012 and 2035: a population-based study. Int J Cancer. 2019;144:49–58.CrossRef Pilleron S, Sarfati D, Janssen-Heijnen M, et al. Global cancer incidence in older adults, 2012 and 2035: a population-based study. Int J Cancer. 2019;144:49–58.CrossRef
3.
go back to reference Parry C, Kent EE, Mariotto AB, et al. Cancer survivors: a booming population. Cancer Epidemiol Biomarkers Prev. 2011;20:1996–2005.CrossRef Parry C, Kent EE, Mariotto AB, et al. Cancer survivors: a booming population. Cancer Epidemiol Biomarkers Prev. 2011;20:1996–2005.CrossRef
5.
go back to reference Hewitt M, Greenfield S, Stovall E. From cancer patient to cancer survivor: Lost in transition. Institute of Medicine, Washington, DC: The National Academies Press. 2006 Hewitt M, Greenfield S, Stovall E. From cancer patient to cancer survivor: Lost in transition. Institute of Medicine, Washington, DC: The National Academies Press. 2006
7.••
go back to reference Arnold M, Rutherford MJ, Bardot A, Ferlay J, Andersson TML, Myklebust TÅ… Bray F. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): A population-based study. Lancet Oncol. 2019;20(11);1493–1505. https://doi.org/10.1016/S1470-2045(19)30456-5. Longitudinal, population-based study in which researchers analyzed patient-level data of 3.9 million patients drawn from population-based cancer registries in seven countries. They calculated age-standardized net survival at 1 and 5 years by tumor site, age group, and period of diagnosis. Arnold M, Rutherford MJ, Bardot A, Ferlay J, Andersson TML, Myklebust TÅ… Bray F. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): A population-based study. Lancet Oncol. 2019;20(11);1493–1505. https://​doi.​org/​10.​1016/​S1470-2045(19)30456-5. Longitudinal, population-based study in which researchers analyzed patient-level data of 3.9 million patients drawn from population-based cancer registries in seven countries. They calculated age-standardized net survival at 1 and 5 years by tumor site, age group, and period of diagnosis.
10.••
go back to reference Guerard EJ, Nightingale G, Bellizzi K, Burhenn P, Rosko A, Artz AS, et al. Survivorship care for older adults with cancer: U13 Conference Report. J Geriatr Oncol. 2016;(4):305-12. https://doi.org/10.1016/j.jgo.2016.06.005. This article presents a summary of the Cancer and Aging Research Group (National Institute on Aging and National Cancer Institute) 2015 conference that discussed survivorship care for older adults. Emerging themes included that survivorship must evolve to meet the needs of older adults; older adult survivors require tailored survivorship care and plans; the suitability of the interdisciplinary team to provide older adult survivorship care; and patient advocacy is needed throughout the care continuum. Guerard EJ, Nightingale G, Bellizzi K, Burhenn P, Rosko A, Artz AS, et al. Survivorship care for older adults with cancer: U13 Conference Report. J Geriatr Oncol. 2016;(4):305-12. https://​doi.​org/​10.​1016/​j.​jgo.​2016.​06.​005. This article presents a summary of the Cancer and Aging Research Group (National Institute on Aging and National Cancer Institute) 2015 conference that discussed survivorship care for older adults. Emerging themes included that survivorship must evolve to meet the needs of older adults; older adult survivors require tailored survivorship care and plans; the suitability of the interdisciplinary team to provide older adult survivorship care; and patient advocacy is needed throughout the care continuum.
11.•
go back to reference Fitch MI, Nicoll I, Lockwood G, Strohschein FJ, Newton L. Main challenges in survivorship transitions: perspectives of older adults with cancer. J Geriatr Oncol. 2021;12(4):632–640. https://doi.org/10.1016/j.jgo.2020.09.024. A secondary analysis of early cancer survivorship for older adults revealing gaps in care and raises concerns about unexamined ageism within the Canadian cancer care system, with the concurrent need for comprehensive geriatric assessments along with multi-modal proactive treatment plans. Fitch MI, Nicoll I, Lockwood G, Strohschein FJ, Newton L. Main challenges in survivorship transitions: perspectives of older adults with cancer. J Geriatr Oncol. 2021;12(4):632–640. https://​doi.​org/​10.​1016/​j.​jgo.​2020.​09.​024. A secondary analysis of early cancer survivorship for older adults revealing gaps in care and raises concerns about unexamined ageism within the Canadian cancer care system, with the concurrent need for comprehensive geriatric assessments along with multi-modal proactive treatment plans.
14.•
go back to reference Fane M, Weeraratna AT. How the ageing microenvironment influences tumour progression. Nat Rev Cancer. 2020;20(2):89–106. https://doi.org/10.1038/s41568-019-0222-9. A review in which the authors discuss how the ageing microenvironment contributes to tumor progression and responses to cancer therapy, including survival. Fane M, Weeraratna AT. How the ageing microenvironment influences tumour progression. Nat Rev Cancer. 2020;20(2):89–106. https://​doi.​org/​10.​1038/​s41568-019-0222-9. A review in which the authors discuss how the ageing microenvironment contributes to tumor progression and responses to cancer therapy, including survival.
15.
go back to reference Outlaw D, Williams GR. Is the lack of evidence in older adults with cancer compromising safety? Expert Opin Drug Saf. 2020;19(9):1059–61.CrossRef Outlaw D, Williams GR. Is the lack of evidence in older adults with cancer compromising safety? Expert Opin Drug Saf. 2020;19(9):1059–61.CrossRef
16.
go back to reference Armenian SH, Gibson CJ, Rockne RC, Ness KK. Premature aging in young cancer survivors. J Natl Cancer Inst. 2019; 111(3):226–232. Armenian SH, Gibson CJ, Rockne RC, Ness KK. Premature aging in young cancer survivors. J Natl Cancer Inst. 2019; 111(3):226–232.
17.••
go back to reference Guida JL, Ahles TA, Belsky D, Campisi J, Cohen HJ, Degregori J… Hurria, A. Measuring aging and identifying aging phenotypes in cancer survivors. J Natl Cancer Inst 2019;111(12):1245–1254. https://doi.org/10.1093/jnci/djz136. Provides a summary of the National Cancer Institute’s 2018 interdisciplinary think tank concerning aging-related consequence of cancer and cancer treatment, which addressed conceptual, measurement, and methodological challenges in this field. Guida JL, Ahles TA, Belsky D, Campisi J, Cohen HJ, Degregori J… Hurria, A. Measuring aging and identifying aging phenotypes in cancer survivors. J Natl Cancer Inst 2019;111(12):1245–1254. https://​doi.​org/​10.​1093/​jnci/​djz136. Provides a summary of the National Cancer Institute’s 2018 interdisciplinary think tank concerning aging-related consequence of cancer and cancer treatment, which addressed conceptual, measurement, and methodological challenges in this field.
19.
go back to reference Gresham G, Dy SM, Zipunnikov V, Browner IS, Studenski SA, Simonsick EM, Ferrucci L, Schrack JA. Fatigability and endurance performance in cancer survivors: analyses from the Baltimore Longitudinal Study of Aging. Cancer. 2018;124(6):1279–87.CrossRef Gresham G, Dy SM, Zipunnikov V, Browner IS, Studenski SA, Simonsick EM, Ferrucci L, Schrack JA. Fatigability and endurance performance in cancer survivors: analyses from the Baltimore Longitudinal Study of Aging. Cancer. 2018;124(6):1279–87.CrossRef
21.••
go back to reference Sedrak MS, Gilmore NJ, Carroll JE, Muss HB, Cohen HJ, Dale W. Measuring biologic resilience in older cancer survivors. J ClinOncol. 2021;39(19):2079–2089. In this review, authors highlight the emerging concept of resilience in older cancer survivors, considering potential biomarkers and interventions that may promote resilience in this population. Sedrak MS, Gilmore NJ, Carroll JE, Muss HB, Cohen HJ, Dale W. Measuring biologic resilience in older cancer survivors. J ClinOncol. 2021;39(19):2079–2089. In this review, authors highlight the emerging concept of resilience in older cancer survivors, considering potential biomarkers and interventions that may promote resilience in this population.
29.
30.••
go back to reference Magnuson A, Sattar S, Nightingale G, Saracino R, Skonecki E, Trevino KM. A practical guide to geriatric syndromes in older adults with cancer: a focus on falls, cognition, polypharmacy, and depression. Am Soc Clin Oncol Educ Book. 2019n;39:e96–e109. https://doi.org/10.1200/EDBK_237641. Identifies potential screening tools to identify geriatric syndromes and highlights the significance of falls, cognitive impairment, polypharmacy, and depression in older adults with cancer. Magnuson A, Sattar S, Nightingale G, Saracino R, Skonecki E, Trevino KM. A practical guide to geriatric syndromes in older adults with cancer: a focus on falls, cognition, polypharmacy, and depression. Am Soc Clin Oncol Educ Book. 2019n;39:e96–e109. https://​doi.​org/​10.​1200/​EDBK_​237641. Identifies potential screening tools to identify geriatric syndromes and highlights the significance of falls, cognitive impairment, polypharmacy, and depression in older adults with cancer.
35.
go back to reference Tometich DB, Small BJ, Carroll JE, Zhai W, Luta G, Zhou X, et al. Thinking and Living with Cancer (TLC) Study. Pretreatment psychoneurological symptoms and their association with longitudinal cognitive function and quality of life in older breast cancer survivors. J Pain Symptom Manage. 2019;57(3):596–606. https://doi.org/10.1016/j.jpainsymman.2018.11.015. Tometich DB, Small BJ, Carroll JE, Zhai W, Luta G, Zhou X, et al. Thinking and Living with Cancer (TLC) Study. Pretreatment psychoneurological symptoms and their association with longitudinal cognitive function and quality of life in older breast cancer survivors. J Pain Symptom Manage. 2019;57(3):596–606. https://​doi.​org/​10.​1016/​j.​jpainsymman.​2018.​11.​015.
42.•
go back to reference Moss JL, Pinto CN, Mama SK, Rincon M, Kent EE, Yu M, Cronin KA. Rural–urban differences in health-related quality of life: patterns for cancer survivors compared to other older adults. Qual Life Res. 2021;30:1131–1143. https://doi.org/10.1007/s11136-020-02683-3. This study has a very large sample size and one of the first to explore rural-urban differences among older cancer survivors. Moss JL, Pinto CN, Mama SK, Rincon M, Kent EE, Yu M, Cronin KA. Rural–urban differences in health-related quality of life: patterns for cancer survivors compared to other older adults. Qual Life Res. 2021;30:1131–1143. https://​doi.​org/​10.​1007/​s11136-020-02683-3. This study has a very large sample size and one of the first to explore rural-urban differences among older cancer survivors.
44.•
go back to reference Shuk D, Cheung T, Takemura N, Chau PH, Yee A, Ng M, Xu X, Lin CC. Exercise levels and preferences on exercise counselling and programming among older cancer survivors: a mixed-methods study. JGO. 2021;12(8):1173–1180.https://doi.org/10.1016/j.jgo.2021.05.00. Study provides interesting insight into the preferences of older adult survivors regarding how exercise programs could be designed with their needs in mind. Shuk D, Cheung T, Takemura N, Chau PH, Yee A, Ng M, Xu X, Lin CC. Exercise levels and preferences on exercise counselling and programming among older cancer survivors: a mixed-methods study. JGO. 2021;12(8):1173–1180.https://​doi.​org/​10.​1016/​j.​jgo.​2021.​05.​00. Study provides interesting insight into the preferences of older adult survivors regarding how exercise programs could be designed with their needs in mind.
46.
go back to reference Brown JC, Narhay MO, Harhay MN. Self-reported major mobility, disability and mortality among cancer survivors. J Geriatr Oncol. 2018; 9(5):459–463. 1016/j.jgo.2018.03.004 Brown JC, Narhay MO, Harhay MN. Self-reported major mobility, disability and mortality among cancer survivors. J Geriatr Oncol. 2018; 9(5):459–463. 1016/j.jgo.2018.03.004
49.•
go back to reference Ramsey SD, Hall IJ, Smith JL, Ekwueme DU, Fedorenko CR, Kreizenbeck K, et al. A comparison of general, genitourinary, bowel, and sexual quality of life among long term survivors of prostate, bladder, colorectal, and lung cancer. J Geriatr Oncol. 2021;12(2):305–311. https://doi.org/10.1016/j.jgo.2020.07.014. This study offers insight into an often-overlooked aspect of quality of life in older adults (sexual activity). It includes a sample of various cancer types. Ramsey SD, Hall IJ, Smith JL, Ekwueme DU, Fedorenko CR, Kreizenbeck K, et al. A comparison of general, genitourinary, bowel, and sexual quality of life among long term survivors of prostate, bladder, colorectal, and lung cancer. J Geriatr Oncol. 2021;12(2):305–311. https://​doi.​org/​10.​1016/​j.​jgo.​2020.​07.​014. This study offers insight into an often-overlooked aspect of quality of life in older adults (sexual activity). It includes a sample of various cancer types.
50.
go back to reference Levkovich I, Cohen, Alon S, Evron E, Pollack S, Fried, et al. Symptom cluster of emotional distress, fatigue and cognitive difficulties among young and older breast cancer survivors: the mediating role f subjective stress. J Geriatr Oncol. 2018;9(5):469–475. 1016/j.jgo.2018.05.002 Levkovich I, Cohen, Alon S, Evron E, Pollack S, Fried, et al. Symptom cluster of emotional distress, fatigue and cognitive difficulties among young and older breast cancer survivors: the mediating role f subjective stress. J Geriatr Oncol. 2018;9(5):469–475. 1016/j.jgo.2018.05.002
53.••
go back to reference Blackwood J, Karczewski H, Huang MH, Pfalzer L. Katz activities of daily living disability in older cancer survivors by age, stage, and cancer type. J Cancer Surviv. 2020;14(6):769–778. https://doi.org/10.1007/s11764-020-00891-x. This article describes the range of potential impairments in activities of daily living cancer survivors could experience. It is a strong case for screening for ADL impairments as a regular aspect of care for older survivors. Blackwood J, Karczewski H, Huang MH, Pfalzer L. Katz activities of daily living disability in older cancer survivors by age, stage, and cancer type. J Cancer Surviv. 2020;14(6):769–778. https://​doi.​org/​10.​1007/​s11764-020-00891-x. This article describes the range of potential impairments in activities of daily living cancer survivors could experience. It is a strong case for screening for ADL impairments as a regular aspect of care for older survivors.
64.•
go back to reference Nishijima TF, Shimokawa M, Esaki T, Morita M, Toh Y, Muss HB. A 10-item frailty index based on a Comprehensive Geriatric Assessment (FI-CGA-10) in Older Adults with Cancer: Development and construct validation. Oncologist. 2021;26(10):e1751–e1760. https://doi.org/10.1002/onco.13894. Study of the creation and testing of a user-friendly frailty index based on comprehensive geriatric assessment with over 500 older adults with various cancer types. Results were determined more quickly and interpreted in a more clinically sensible manner than existing tools. Nishijima TF, Shimokawa M, Esaki T, Morita M, Toh Y, Muss HB. A 10-item frailty index based on a Comprehensive Geriatric Assessment (FI-CGA-10) in Older Adults with Cancer: Development and construct validation. Oncologist. 2021;26(10):e1751–e1760. https://​doi.​org/​10.​1002/​onco.​13894. Study of the creation and testing of a user-friendly frailty index based on comprehensive geriatric assessment with over 500 older adults with various cancer types. Results were determined more quickly and interpreted in a more clinically sensible manner than existing tools.
66.••
go back to reference Overcash J, Ford N, Kress E, Ubbing C, Williams N. Comprehensive Geriatric Assessment as a versatile tool to enhance the care of the older person diagnosed with cancer. Geriatrics (Basel). 2019;24;4(2):39. https://doi.org/10.3390/geriatrics4020039. Examination of how a comprehensive geriatric assessment can be tailored to ambulatory geriatric oncology programs in academic cancer centers and to community oncology practices with varying levels of resources. Overcash J, Ford N, Kress E, Ubbing C, Williams N. Comprehensive Geriatric Assessment as a versatile tool to enhance the care of the older person diagnosed with cancer. Geriatrics (Basel). 2019;24;4(2):39. https://​doi.​org/​10.​3390/​geriatrics402003​9. Examination of how a comprehensive geriatric assessment can be tailored to ambulatory geriatric oncology programs in academic cancer centers and to community oncology practices with varying levels of resources.
69.••
go back to reference Forbes C, Swan F, Greenley SL, Lind M, Johnson MJ. Physical activity and nutrition interventions for older adults with cancer: A systematic review. Journal of Cancer Survivorship. 2020;14:689–711. https://doi.org/10.1007/s11764-020-00883-x / Published online: 24 April 2020. A recent literature review of effectiveness of physical activity interventions for older adult cancer survivors describes various interventions and can inform future designs. Forbes C, Swan F, Greenley SL, Lind M, Johnson MJ. Physical activity and nutrition interventions for older adults with cancer: A systematic review. Journal of Cancer Survivorship. 2020;14:689–711. https://​doi.​org/​10.​1007/​s11764-020-00883-x / Published online: 24 April 2020. A recent literature review of effectiveness of physical activity interventions for older adult cancer survivors describes various interventions and can inform future designs.
70.
71.
75.
77.
go back to reference Strohschein FJ. Newton L. Fitch MI, Haase K, Puts MTE, Jin R, Loucks A, Kenis C. Optimizing care of older adults with cancer: Canadian perspectives on challenges, solutions, and the need for interprofessional collaboration. Canadian Association of Psychosocial Oncology National Virtual Conference, July 14-16, 2020. Strohschein FJ. Newton L. Fitch MI, Haase K, Puts MTE, Jin R, Loucks A, Kenis C. Optimizing care of older adults with cancer: Canadian perspectives on challenges, solutions, and the need for interprofessional collaboration. Canadian Association of Psychosocial Oncology National Virtual Conference, July 14-16, 2020.
79.
go back to reference Strohschein FJ, Newton L, Puts M, Jin R, Haase, K, Plante A, Loucks A, Kenis C, Fitch MI. Optimizing the care of older Canadians with cancer and their families: a statement articulating the position and contribution of Canadian oncology nurses. Can Oncol Nurs J = Revue canadienne de nursing oncologique. 2021;31(3):352–356. Strohschein FJ, Newton L, Puts M, Jin R, Haase, K, Plante A, Loucks A, Kenis C, Fitch MI. Optimizing the care of older Canadians with cancer and their families: a statement articulating the position and contribution of Canadian oncology nurses. Can Oncol Nurs J = Revue canadienne de nursing oncologique. 2021;31(3):352–356.
86.•
go back to reference Beuthin R, Bruce A, Scaia M. Medical assistance in dying (MAiD): Canadian nurses’ experiences. Nurs Forum. 2018;53:511–520. https://doi.org/10.1111/nuf.12280. A Canadian descriptive narrative inquiry examining nurses’ experiences in the first six months of MAiD legalization, highlighting professional impacts of, and the importance of, open and non-judgemental communication with and between patients, families and the multidisciplinary healthcare team. Beuthin R, Bruce A, Scaia M. Medical assistance in dying (MAiD): Canadian nurses’ experiences. Nurs Forum. 2018;53:511–520. https://​doi.​org/​10.​1111/​nuf.​12280. A Canadian descriptive narrative inquiry examining nurses’ experiences in the first six months of MAiD legalization, highlighting professional impacts of, and the importance of, open and non-judgemental communication with and between patients, families and the multidisciplinary healthcare team.
87.•
go back to reference Selby, D, Bean, S, Isenberg-Grzeda, E, Bioethics, B, & Nolen, A. Medical Assistance in Dying (MAiD): A Descriptive study from a Canadian tertiary care hospital. Am J Hospice Palliat Care. 2020;37(1):58–64. https://doi.org/10.1177/1049909119859844. A retrospective chart review was conducted to better understand the nature of MAiD requests in a Canadian healthcare institution, finding similarities with requests to other jurisdictions, and indicating that earlier assessments and more careful monitoring would be beneficial for this group at high risk for loss of capacity. Selby, D, Bean, S, Isenberg-Grzeda, E, Bioethics, B, & Nolen, A. Medical Assistance in Dying (MAiD): A Descriptive study from a Canadian tertiary care hospital. Am J Hospice Palliat Care. 2020;37(1):58–64. https://​doi.​org/​10.​1177/​1049909119859844​. A retrospective chart review was conducted to better understand the nature of MAiD requests in a Canadian healthcare institution, finding similarities with requests to other jurisdictions, and indicating that earlier assessments and more careful monitoring would be beneficial for this group at high risk for loss of capacity.
88.•
go back to reference Blanke C, LeBlanc M, Hershman D, Ellis L, Meyskens F. (2017). Characterizing 18 years of the death with dignity act in Oregon. JAMA Oncol 2017;3(10):1403–1406. https://doi.org/10.1001/jamaoncol.2017.0243. This analysis of publicly available data illuminates how MAiD in the USA is enacted and corroborates how cancer is the prevalent diagnosis of those choosing this option. Blanke C, LeBlanc M, Hershman D, Ellis L, Meyskens F. (2017). Characterizing 18 years of the death with dignity act in Oregon. JAMA Oncol 2017;3(10):1403–1406. https://​doi.​org/​10.​1001/​jamaoncol.​2017.​0243. This analysis of publicly available data illuminates how MAiD in the USA is enacted and corroborates how cancer is the prevalent diagnosis of those choosing this option.
89.
go back to reference Emanuel IJ, Onwuteaka-Philipsen BD, Unwin JW, Cohen J. Attitudes and practices of euthanasia and physician-assisted suicide in the United States, Canada and Europe. JAMA. 2016;316:79–90. Comprehensive review of practices across Europe and North America with extensive data on differing approaches and experiences. Emanuel IJ, Onwuteaka-Philipsen BD, Unwin JW, Cohen J. Attitudes and practices of euthanasia and physician-assisted suicide in the United States, Canada and Europe. JAMA. 2016;316:79–90. Comprehensive review of practices across Europe and North America with extensive data on differing approaches and experiences.
91.•
go back to reference Selby D, Bean S. Oncologists communicating with patients about assisted dying. Curr Opin Support Palliat Care. 2019;13(1):59–63. https://doi.org/10.1097/SPC.0000000000000411. A review of recent literature regarding MAiD and communication revealed key themes of perceived barriers and benefits, including the importance of pragmatic and proactive approaches o develop and support best practices Selby D, Bean S. Oncologists communicating with patients about assisted dying. Curr Opin Support Palliat Care. 2019;13(1):59–63. https://​doi.​org/​10.​1097/​SPC.​0000000000000411​. A review of recent literature regarding MAiD and communication revealed key themes of perceived barriers and benefits, including the importance of pragmatic and proactive approaches o develop and support best practices
92.••
go back to reference Chandhoke G, Pond G, Levine O, Oczkowski S. Oncologists and medical assistance in dying: where do we stand? Results of a national survey of Canadian oncologists. Curr Oncol (Toronto, Ont.), 2020;27(5):263–269. https://doi.org/10.3747/co.27.6295. An overview of survey finding to better understand Canadian oncologists’ experiences with MAiD, in which 70% of respondents received MAiD requests, supporting calls for standardized guidelines to safeguard equitable access for oncology patients. Chandhoke G, Pond G, Levine O, Oczkowski S. Oncologists and medical assistance in dying: where do we stand? Results of a national survey of Canadian oncologists. Curr Oncol (Toronto, Ont.), 2020;27(5):263–269. https://​doi.​org/​10.​3747/​co.​27.​6295. An overview of survey finding to better understand Canadian oncologists’ experiences with MAiD, in which 70% of respondents received MAiD requests, supporting calls for standardized guidelines to safeguard equitable access for oncology patients.
93.•
go back to reference Li M, Shapiro GK, Klein R, et al. Medical Assistance in Dying in patients with advanced cancer and their caregivers: a mixed methods longitudinal study protocol. BMC Palliat Care, 2021;117. https://doi.org/10.1186/s12904-021-00793-4. This Canadian study is aimed to excavate the prevalence and determinants of depression and demoralization and how these states influence desire for death and MAiD requests, pointing to the importance of appropriate access and further consideration as the legislation for MAiD is broadening. Li M, Shapiro GK, Klein R, et al. Medical Assistance in Dying in patients with advanced cancer and their caregivers: a mixed methods longitudinal study protocol. BMC Palliat Care, 2021;117. https://​doi.​org/​10.​1186/​s12904-021-00793-4. This Canadian study is aimed to excavate the prevalence and determinants of depression and demoralization and how these states influence desire for death and MAiD requests, pointing to the importance of appropriate access and further consideration as the legislation for MAiD is broadening.
96.••
go back to reference Pesut B, Thorne S, Schiller C, Greig M, Roussel J, Tishelman C. (2020). Constructing good nursing practice for medical assistance in dying in Canada: an interpretive descriptive study. Glob QualNurs Res. 2020;7:2333393620938686https://doi.org/10.1177/2333393620938686. The purpose of this qualitative study was to explore ‘good nursing practice’ in the context of MAiD to humanize a somewhat medicalized experience, which includes establishing relationships, planning and supporting the family and underscores the need for best practice guidelines development. Pesut B, Thorne S, Schiller C, Greig M, Roussel J, Tishelman C. (2020). Constructing good nursing practice for medical assistance in dying in Canada: an interpretive descriptive study. Glob QualNurs Res. 2020;7:2333393620938686https://​doi.​org/​10.​1177/​2333393620938686​. The purpose of this qualitative study was to explore ‘good nursing practice’ in the context of MAiD to humanize a somewhat medicalized experience, which includes establishing relationships, planning and supporting the family and underscores the need for best practice guidelines development.
97.
go back to reference National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®): Older adult oncology (Version 1.2021). 2021. Available from: www.nccn.org. Accessed 2 Jan 2022. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®): Older adult oncology (Version 1.2021). 2021. Available from: www.​nccn.​org. Accessed 2 Jan 2022.
98.
go back to reference Mohile SG, Dale W, Somerfield MR, Schonberg MA, Boyd CM, Burhenn PS, et al. Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology. J Clin Oncol. 2018;36:2326–47.CrossRef Mohile SG, Dale W, Somerfield MR, Schonberg MA, Boyd CM, Burhenn PS, et al. Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology. J Clin Oncol. 2018;36:2326–47.CrossRef
99.
go back to reference Extermann M, Brain E, Canin B, Cherian MN, Cheung K-L, de Glas N, et al. Priorities for the global advancement of care for older adults with cancer: an update of the International Society of Geriatric Oncology Priorities Initiative. Lancet Oncol. 2021;22(1):e29–36.CrossRef Extermann M, Brain E, Canin B, Cherian MN, Cheung K-L, de Glas N, et al. Priorities for the global advancement of care for older adults with cancer: an update of the International Society of Geriatric Oncology Priorities Initiative. Lancet Oncol. 2021;22(1):e29–36.CrossRef
100.
go back to reference Puts M, Strohschein F, Oldenmenger W, Haase K, Newton L, Fitch M, et al. Position statement on oncology and cancer nursing care for older adults with cancer and their caregivers of the International Society of Geriatric Oncology Nursing and Allied Health Interest Group, the Canadian Association of Nurses in Oncology Oncology & Aging Special Interest Group, and the European Oncology Nursing Society. J Geriatr Oncol. 2021;12(7):1000–4.CrossRef Puts M, Strohschein F, Oldenmenger W, Haase K, Newton L, Fitch M, et al. Position statement on oncology and cancer nursing care for older adults with cancer and their caregivers of the International Society of Geriatric Oncology Nursing and Allied Health Interest Group, the Canadian Association of Nurses in Oncology Oncology & Aging Special Interest Group, and the European Oncology Nursing Society. J Geriatr Oncol. 2021;12(7):1000–4.CrossRef
101.
go back to reference Scotté F, Bossi P, Carola E, Cudennec T, Dielenseger P, Gomes F, et al. Addressing the quality of life needs of older patients with cancer: a SIOG consensus paper and practical guide. Ann Oncol. 2018;29(8):1718–26.CrossRef Scotté F, Bossi P, Carola E, Cudennec T, Dielenseger P, Gomes F, et al. Addressing the quality of life needs of older patients with cancer: a SIOG consensus paper and practical guide. Ann Oncol. 2018;29(8):1718–26.CrossRef
Metadata
Title
Challenges of Survivorship for Older Adults Diagnosed with Cancer
Authors
Margaret I. Fitch
Irene Nicoll
Lorelei Newton
Fay J. Strohschein
Publication date
01-06-2022
Publisher
Springer US
Keyword
Care
Published in
Current Oncology Reports / Issue 6/2022
Print ISSN: 1523-3790
Electronic ISSN: 1534-6269
DOI
https://doi.org/10.1007/s11912-022-01255-7

Other articles of this Issue 6/2022

Current Oncology Reports 6/2022 Go to the issue

Pediatric Oncology (KL Davis, Section Editor)

Neutropenia and Infection Prophylaxis in Childhood Cancer

Neuroendocrine Neoplasms (NS Reed, Section Editor)

Neuroendocrine Tumors: a Relevant Clinical Update

Cancer Rehabilitation (S Shahpar, Section Editor)

Rehabilitation Needs for Patients Undergoing CAR T-Cell Therapy

Genitourinary Cancers (DP Petrylak and JW Kim, Section Editors)

Approaches to First-Line Therapy for Metastatic Clear Cell Renal Cell Carcinoma

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine